4-peptide melanoma vaccine (Eisai/University of Chicago)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug Name4-peptide melanoma vaccine (Eisai/University of Chicago)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEisai Co LtdThe University Of Chicago
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of ChicagoEisai Inc
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A